GenKyoTex S.A. Announces Leadership Transition

GENEVA & ARCHAMPS, France--(BUSINESS WIRE)--Genkyotex, the leading developer of selective NOX inhibitors, announced today that Dr. Ursula M. Ney has resigned as chief executive officer and as a member of the Board of Directors effective September 30th 2015. Genkyotex’s Board of Directors has promoted Elias Papatheodorou to the role of acting Chief Executive Officer and Dr. Philippe Wiesel to Executive Vice President and Chief Medical Officer. Mr. Papatheodorou joined Genkyotex in March 2015 as Chief Business Officer.

Help employers find you! Check out all the jobs and post your resume.

Back to news